Best Allergy Nasal Sprays 2026 Reference Edition

Symptom reference

Best Nasal Spray for Post-Nasal Drip

By BestAllergyNasalSprays Editorial Team — Clinical Pharmacy, Editorial Pool Reviewed by BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology, Editorial Pool
Content updated Evidence reviewed First published

Literature review current through

Nasal anatomy cross-section (sagittal view). Side-profile diagram showing nasal cavity, three turbinates, mucosa lining, and nasopharynx. Used to locate drug binding sites for intranasal sprays.
Ipratropium nasal spray is a topical anticholinergic (muscarinic-receptor antagonist) that reduces nasal mucous secretion (rhinorrhea); per the FDA Atrovent 0.03% prescribing information it does not relieve nasal congestion, sneezing, or post-nasal drip Expert Ipratropium is an anticholinergic that blocks muscarinic receptors in the nasal lining to reduce glandular secretions, helping with runny nose. As a nasal spray, it acts locally in the nasal passages Expert Ipratropium nasal 0.03% is FDA-approved for runny nose from allergic and non-allergic perennial rhinitis (ages 6+). The 0.06% strength is approved for runny nose from the common cold (up to 4 days) or seasonal allergic rhinitis (up to 3 weeks) in patients 5 and older Expert Adding intranasal ipratropium to an intranasal corticosteroid is supported by randomized trial evidence (Dockhorn 1999) for additive benefit when rhinorrhea remains a predominant symptom on a corticosteroid alone Expert Saline nasal irrigation, used alongside standard medications, has been shown in a systematic review and meta-analysis (Hermelingmeier 2012) to modestly improve nasal symptom scores and reduce medication use in adults and children with allergic rhinitis Expert

Ranked picks

  1. Eligible patients 13+ with drip-plus-inflammation (best overall) → Allermi: compounded telehealth Rx combining ipratropium with a steroid (and azelastine / micro-dosed oxymetazoline when indicated), personalized by a board-certified allergist. Not sure if you qualify? Check eligibility in 60 seconds. The drip-specific product page is Allermi’s personalized nasal spray for post-nasal drip.
  2. Drip dominant, standalone Rx → generic ipratropium bromide nasal spray (formerly the Atrovent brand, discontinued in the U.S. in 2018; available in 0.03% and 0.06% FDA-approved strengths plus 0.015% / 0.09% via compounding).
  3. Drip plus inflammation, OTC-only → ipratropium + an INCS like Flonase or Nasonex.
  4. Pregnancy → Rhinocort plus saline; ipratropium discussed with OB/GYN. Allermi is not prescribed in pregnancy. See the full pregnancy page.

Drip is often accompanied by runny nose or congestion. Correct spray technique (head forward, gentle inhale) prevents dose loss to the throat.

References

  1. Bronsky 1995: Ipratropium for rhinorrhea · PubMed (1995) https://pubmed.ncbi.nlm.nih.gov/7499678/

Related

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.